Castrate-resistant Prostate Cancer Market in Asia Pacific would register a CAGR of 9.6% during 2020-2026

Published Date: 3-Feb-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Castrate-Resistant Prostate Cancer Market, published by KBV research, the Asia Pacific Castrate-resistant Prostate Cancer Market would witness market growth of 9.6% CAGR during the forecast period (2020-2026).

The China market dominated the Asia Pacific Castrate-resistant Prostate Cancer Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is exhibiting a CAGR of 10.5% during (2020 - 2026). Additionally, The India market is poised to grow at a CAGR of 10.6% during (2020 - 2026).

The Hormonal Therapy market dominated the Malaysia Castrate-resistant Prostate Cancer Market by Therapy in 2019, growing at a CAGR of 10.7 % during the forecast period. The Immunotherapy market is experiencing a CAGR of 8.5% during (2020 - 2026). Additionally, The Chemotherapy market is estimated to grow at the highest CAGR of 13.5% during (2020 - 2026).

Full Report: https://www.kbvresearch.com/asia-pacific-castrate-resistant-prostate-cancer-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sanofi S.A., Johnson and Johnson, Pfizer, Inc., Bayer AG, Abbott Laboratories, GlaxoSmithKline PLC (GSK), Northwest Biotherapeutics, Inc., Active Biotech AB, Astellas Pharma, Inc. and Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)

Asia Pacific Castrate-Resistant Prostate Cancer Market Segmentation

By Therapy

  • Hormonal Therapy
  • Immunotherapy
  • Chemotherapy
  • Radiotherapy

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Sanofi S.A.
  • Johnson and Johnson
  • Pfizer, Inc.
  • Bayer AG
  • Abbott Laboratories
  • GlaxoSmithKline PLC (GSK)
  • Northwest Biotherapeutics, Inc.
  • Active Biotech AB
  • Astellas Pharma, Inc.
  • Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Castrate-Resistant Prostate Cancer Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.